Orthocell (ASX $OCC) has been featured in a story titled “WA training for the heavyweight fight”, published in The West Australian’s Business section this weekend.
Business journalist Cheyanne Enciso spoke with Orthocell’s Managing Director, Paul Anderson about the Company’s landmark $23.1 million licensing and manufacturing deal for Striate+™ with BioHorizons last year, and its significance for Australia’s manufacturing sector.
In Paul’s words:
“The market is dominated by five (global) companies and so you either play with the big boys, or you chip around the edges. We are not here as a company to bite little bits off at the edges.”